Blue Water Life Science Advisors

Latest statistics and disclosures from Blue Water Life Science Advisors's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NTRA, AKYA, GH, TXG, QTRX, and represent 88.80% of Blue Water Life Science Advisors's stock portfolio.
  • Added to shares of these 3 stocks: NTRA (+$9.7M), EXAS, QTRX.
  • Started 1 new stock position in EXAS.
  • Reduced shares in these 3 stocks: TMO (-$14M), MXCT (-$5.4M), NSTGQ.
  • Sold out of its positions in NSTGQ, TMO.
  • Blue Water Life Science Advisors was a net seller of stock by $-6.3M.
  • Blue Water Life Science Advisors has $106M in assets under management (AUM), dropping by -6.88%.
  • Central Index Key (CIK): 0001789778

Tip: Access up to 7 years of quarterly data

Positions held by Blue Water Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Blue Water Life Science Advisors

Blue Water Life Science Advisors holds 8 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Natera (NTRA) 43.3 $46M +26% 503k 91.46
 View chart
Akoya Biosciences (AKYA) 20.7 $22M 4.7M 4.69
 View chart
Guardant Health (GH) 11.1 $12M 571k 20.63
 View chart
10x Genomics Cl A Com (TXG) 6.9 $7.3M 195k 37.53
 View chart
Quanterix Ord (QTRX) 6.8 $7.3M +7% 309k 23.56
 View chart
Adaptive Biotechnologies Cor (ADPT) 5.1 $5.4M 1.7M 3.21
 View chart
EXACT Sciences Corporation (EXAS) 3.7 $4.0M NEW 57k 69.06
 View chart
Maxcyte (MXCT) 2.4 $2.5M -67% 604k 4.19
 View chart

Past Filings by Blue Water Life Science Advisors

SEC 13F filings are viewable for Blue Water Life Science Advisors going back to 2020